Search by Drug Name or NDC

NDC 11523-7234-02 MiraLAX 17 g/17g Details

MiraLAX 17 g/17g

MiraLAX is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Bayer HealthCare LLC.. The primary component is POLYETHYLENE GLYCOL 3350.

MedlinePlus Drug Summary

Polyethylene glycol 3350 is used to treat occasional constipation. Polyethylene glycol 3350 is in a class of medications called osmotic laxatives. It works by causing water to be retained with the stool. This increases the number of bowel movements and softens the stool so it is easier to pass.

Related Packages: 11523-7234-02
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Polyethylene Glycol 3350

Product Information

NDC	11523-7234
Product ID	11523-7234_0bb62586-406e-f7e0-e063-6394a90a2b74
Associated GPIs	46600033003020 46600033002910
GCN Sequence Number	034313
GCN Sequence Number Description	polyethylene glycol 3350 POWD PACK 17 G ORAL
HIC3	D6S
HIC3 Description	LAXATIVES AND CATHARTICS
GCN	86211
HICL Sequence Number	022819
HICL Sequence Number Description	POLYETHYLENE GLYCOL 3350
Brand/Generic	Brand
Proprietary Name	MiraLAX
Proprietary Name Suffix	n/a
Non-Proprietary Name	Polyethylene Glycol 3350
Product Type	HUMAN OTC DRUG
Dosage Form	POWDER, FOR SOLUTION
Route	ORAL
Active Ingredient Strength	17
Active Ingredient Units	g/17g
Substance Name	POLYETHYLENE GLYCOL 3350
Labeler Name	Bayer HealthCare LLC.
Pharmaceutical Class	Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA022015
Listing Certified Through	2024-12-31

Package

NDC 11523-7234-02 (11523723402)

Pricing Information	N/A
NDC Package Code	11523-7234-2
Billing NDC	11523723402
Package	119 g in 1 BOTTLE, PLASTIC (11523-7234-2)
Marketing Start Date	2007-02-01
NDC Exclude Flag	N